Kala Pharmaceuticals, a stealthy Waltham, MA-based biotech startup, has raised $3 million in an equity and debt financing, according to an SEC filing. The firm’s board of directors includes the famous MIT inventor Bob Langer, Robert Paull, a managing partner of Lux Capital, Kevin Bitterman, a principal at Polaris Venture Partners, Justin Hanes, a professor of chemical and biomolecular engineering at Johns Hopkins University, and Robert Tepper, a partner at Third Rock Ventures, according to the filing. The startup previously raised $2 million in an equity financing in December 2009. The company does not appear to have a website, and it’s unclear what its specific focus is.
Author: Ryan McBride
Ryan is an award-winning business journalist who contributes to our life sciences and technology coverage. He was previously a staff writer for Mass High Tech, a Boston business and technology newspaper, where he and his colleagues won a national business journalism award from the Society of American Business Editors and Writers in 2008. In recent years, he has made regular TV appearances on New England Cable News.
Prior to MHT, Ryan covered the life sciences, technology, and energy sectors for Providence Business News. He graduated with honors from the University of Rhode Island in 2001 with a bachelor’s degree in communications. When he’s not chasing down news, Ryan enjoys mountain biking and skiing in his home state of Vermont.
View all posts by Ryan McBride
